Cross-classification analysis reveals hyperuricemia's role in kidney prognosis across age and sex in ADPKD, suggesting personalized care approaches.
Hyperuricemia may contribute to disease progression in autosomal dominant polycystic kidney disease (ADPKD), but its prognostic impact remains unclear, especially across sex and age groups. Given the need for individualized care, we investigated the association between hyperuricemia and kidney prognosis using an attribute-based cross-classification approach by sex and age.
No takes yet. Share an insight, caveat, or question.
Kataoka et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: